US Stock MarketDetailed Quotes

Arbutus Biopharma (ABUS)

Watchlist
  • 4.240
  • -0.110-2.53%
Close May 15 16:00 ET
  • 4.240
  • 0.0000.00%
Post 20:01 ET
837.56MMarket Cap5.11P/E (TTM)

Arbutus Biopharma (ABUS) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-15.51%95.23M
-25.40%91.47M
-25.40%91.47M
-26.68%93.7M
-30.92%98.09M
-12.79%112.71M
-2.68%122.62M
-2.68%122.62M
-4.76%127.79M
-6.88%141.99M
-Cash and cash equivalents
-36.06%23.71M
-50.43%18.01M
-50.43%18.01M
-29.64%22.41M
-40.42%37.41M
-13.98%37.08M
38.22%36.33M
38.22%36.33M
81.66%31.85M
130.86%62.79M
-Short-term investments
-5.44%71.52M
-14.87%73.46M
-14.87%73.46M
-25.70%71.29M
-23.39%60.68M
-12.20%75.63M
-13.46%86.29M
-13.46%86.29M
-17.75%95.95M
-36.79%79.2M
Receivables
15,132.91%180.05M
-39.93%1.45M
-39.93%1.45M
-43.72%905K
-41.99%1.03M
-44.74%1.18M
35.64%2.41M
35.64%2.41M
-25.93%1.61M
-32.40%1.77M
-Accounts receivable
11.00%1.31M
-39.93%1.45M
-39.93%1.45M
-43.72%905K
-41.99%1.03M
-44.74%1.18M
35.64%2.41M
35.64%2.41M
-25.93%1.61M
-32.40%1.77M
-Other receivables
--178.74M
----
----
----
----
----
----
----
----
----
Other current assets
-40.66%1.73M
-32.66%1.54M
-32.66%1.54M
-16.00%2.84M
-10.32%4.01M
-35.03%2.92M
-46.23%2.28M
-46.23%2.28M
-35.79%3.38M
20.66%4.47M
Total current assets
137.15%277.01M
-25.81%94.46M
-25.81%94.46M
-26.61%97.44M
-30.43%103.12M
-14.03%116.81M
-3.57%127.32M
-3.57%127.32M
-6.24%132.78M
-6.66%148.22M
Non current assets
Net PPE
-86.90%22K
-99.27%32K
-99.27%32K
-97.09%137K
-97.21%148K
-97.07%168K
-28.46%4.36M
-28.46%4.36M
-28.08%4.7M
-23.85%5.3M
-Gross PPE
-98.18%246K
-98.59%245K
-98.59%245K
-22.34%13.48M
-24.82%13.46M
-25.02%13.49M
-3.54%17.35M
-3.54%17.35M
-3.94%17.36M
-2.85%17.91M
-Accumulated depreciation
98.32%-224K
98.36%-213K
98.36%-213K
-5.40%-13.35M
-5.58%-13.32M
-8.73%-13.33M
-9.21%-13M
-9.21%-13M
-9.72%-12.66M
-9.88%-12.61M
Investments and advances
----
----
----
----
----
----
--0
--0
-71.76%2.96M
-40.97%6.53M
Other non current assets
285.29%131K
282.35%130K
282.35%130K
--131K
----
--34K
--34K
--34K
----
----
Total non current assets
-24.26%153K
-96.31%162K
-96.31%162K
-96.50%268K
-98.75%148K
-98.60%202K
-64.51%4.39M
-64.51%4.39M
-55.01%7.66M
-34.40%11.82M
Total assets
136.87%277.16M
-28.16%94.62M
-28.16%94.62M
-30.43%97.71M
-35.48%103.27M
-22.14%117.01M
-8.79%131.71M
-8.79%131.71M
-11.47%140.44M
-9.49%160.04M
Liabilities
Current liabilities
Payables
-34.73%1.46M
-49.35%1.17M
-49.35%1.17M
-56.33%1.01M
-50.19%1.32M
-40.15%2.24M
-28.14%2.32M
-28.14%2.32M
2.43%2.32M
154.02%2.65M
-accounts payable
-34.73%1.46M
-49.35%1.17M
-49.35%1.17M
-56.33%1.01M
-50.19%1.32M
-40.15%2.24M
-28.14%2.32M
-28.14%2.32M
2.43%2.32M
154.02%2.65M
Current accrued expenses
-29.12%2.77M
-30.53%3.65M
-30.53%3.65M
-38.27%2.88M
-71.39%2.42M
-13.32%3.9M
-25.54%5.25M
-25.54%5.25M
-38.19%4.66M
8.96%8.46M
Current debt and capital lease obligation
12.08%631K
13.25%547K
13.25%547K
13.46%531K
13.47%514K
12.15%563K
13.65%483K
13.65%483K
13.59%468K
14.11%453K
-Current capital lease obligation
12.08%631K
13.25%547K
13.25%547K
13.46%531K
13.47%514K
12.15%563K
13.65%483K
13.65%483K
13.59%468K
14.11%453K
Current deferred liabilities
----
--0
--0
--0
--0
-41.47%6.76M
-35.79%7.57M
-35.79%7.57M
-9.87%10.91M
-28.01%11.03M
Other current liabilities
-95.89%245K
--640K
--640K
35.04%763K
--768K
--5.97M
----
----
--565K
----
Current liabilities
-73.73%5.11M
-61.54%6.01M
-61.54%6.01M
-72.60%5.18M
-77.77%5.02M
-4.26%19.43M
-30.55%15.62M
-30.55%15.62M
-15.23%18.92M
-7.88%22.6M
Non current liabilities
Long term debt and capital lease obligation
--0
-75.31%199K
-75.31%199K
-60.02%391K
-49.74%575K
-46.99%626K
-39.99%806K
-39.99%806K
-34.67%978K
-30.50%1.14M
-Long term capital lease obligation
--0
-75.31%199K
-75.31%199K
-60.02%391K
-49.74%575K
-46.99%626K
-39.99%806K
-39.99%806K
-34.67%978K
-30.50%1.14M
Non current deferred liabilities
----
--0
--0
--0
--0
--2.86M
--2.86M
--2.86M
----
----
Other non current liabilities
-20.43%11.88M
-21.37%11.84M
-21.37%11.84M
7.96%14.74M
6.09%14.69M
5.34%14.93M
3.44%15.05M
3.44%15.05M
-11.84%13.65M
-13.19%13.85M
Total non current liabilities
-35.50%11.88M
-35.72%12.04M
-35.72%12.04M
3.41%15.13M
1.83%15.27M
19.96%18.42M
17.78%18.72M
17.78%18.72M
-13.85%14.63M
-14.81%14.99M
Total liabilities
-55.12%16.99M
-47.46%18.04M
-47.46%18.04M
-39.46%20.31M
-46.02%20.29M
6.17%37.85M
-10.53%34.34M
-10.53%34.34M
-14.64%33.55M
-10.78%37.59M
Shareholders'equity
Share capital
1.99%1.44B
0.81%1.42B
0.81%1.42B
0.78%1.42B
0.98%1.42B
2.83%1.42B
4.46%1.41B
4.46%1.41B
4.57%1.41B
4.40%1.4B
-common stock
1.99%1.44B
0.81%1.42B
0.81%1.42B
0.78%1.42B
0.98%1.42B
2.83%1.42B
4.46%1.41B
4.46%1.41B
4.57%1.41B
4.40%1.4B
Retained earnings
11.72%-1.21B
-2.49%-1.38B
-2.49%-1.38B
-3.17%-1.38B
-4.13%-1.37B
-5.91%-1.37B
-5.48%-1.35B
-5.48%-1.35B
-6.10%-1.33B
-6.23%-1.31B
Paid-in capital
-9.54%74.26M
1.55%83.32M
1.55%83.32M
2.28%83.29M
1.07%82.63M
2.33%82.09M
0.96%82.05M
0.96%82.05M
2.36%81.43M
5.89%81.75M
Gains losses not affecting retained earnings
-0.06%-48.2M
0.08%-48.1M
0.08%-48.1M
-0.08%-48.13M
0.25%-48.19M
0.42%-48.17M
0.59%-48.14M
0.59%-48.14M
1.62%-48.09M
2.34%-48.31M
Total stockholders'equity
228.68%260.18M
-21.35%76.58M
-21.35%76.58M
-27.59%77.4M
-32.24%82.98M
-30.95%79.16M
-8.16%97.37M
-8.16%97.37M
-10.43%106.89M
-9.09%122.45M
Total equity
228.68%260.18M
-21.35%76.58M
-21.35%76.58M
-27.59%77.4M
-32.24%82.98M
-30.95%79.16M
-8.16%97.37M
-8.16%97.37M
-10.43%106.89M
-9.09%122.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -15.51%95.23M-25.40%91.47M-25.40%91.47M-26.68%93.7M-30.92%98.09M-12.79%112.71M-2.68%122.62M-2.68%122.62M-4.76%127.79M-6.88%141.99M
-Cash and cash equivalents -36.06%23.71M-50.43%18.01M-50.43%18.01M-29.64%22.41M-40.42%37.41M-13.98%37.08M38.22%36.33M38.22%36.33M81.66%31.85M130.86%62.79M
-Short-term investments -5.44%71.52M-14.87%73.46M-14.87%73.46M-25.70%71.29M-23.39%60.68M-12.20%75.63M-13.46%86.29M-13.46%86.29M-17.75%95.95M-36.79%79.2M
Receivables 15,132.91%180.05M-39.93%1.45M-39.93%1.45M-43.72%905K-41.99%1.03M-44.74%1.18M35.64%2.41M35.64%2.41M-25.93%1.61M-32.40%1.77M
-Accounts receivable 11.00%1.31M-39.93%1.45M-39.93%1.45M-43.72%905K-41.99%1.03M-44.74%1.18M35.64%2.41M35.64%2.41M-25.93%1.61M-32.40%1.77M
-Other receivables --178.74M------------------------------------
Other current assets -40.66%1.73M-32.66%1.54M-32.66%1.54M-16.00%2.84M-10.32%4.01M-35.03%2.92M-46.23%2.28M-46.23%2.28M-35.79%3.38M20.66%4.47M
Total current assets 137.15%277.01M-25.81%94.46M-25.81%94.46M-26.61%97.44M-30.43%103.12M-14.03%116.81M-3.57%127.32M-3.57%127.32M-6.24%132.78M-6.66%148.22M
Non current assets
Net PPE -86.90%22K-99.27%32K-99.27%32K-97.09%137K-97.21%148K-97.07%168K-28.46%4.36M-28.46%4.36M-28.08%4.7M-23.85%5.3M
-Gross PPE -98.18%246K-98.59%245K-98.59%245K-22.34%13.48M-24.82%13.46M-25.02%13.49M-3.54%17.35M-3.54%17.35M-3.94%17.36M-2.85%17.91M
-Accumulated depreciation 98.32%-224K98.36%-213K98.36%-213K-5.40%-13.35M-5.58%-13.32M-8.73%-13.33M-9.21%-13M-9.21%-13M-9.72%-12.66M-9.88%-12.61M
Investments and advances --------------------------0--0-71.76%2.96M-40.97%6.53M
Other non current assets 285.29%131K282.35%130K282.35%130K--131K------34K--34K--34K--------
Total non current assets -24.26%153K-96.31%162K-96.31%162K-96.50%268K-98.75%148K-98.60%202K-64.51%4.39M-64.51%4.39M-55.01%7.66M-34.40%11.82M
Total assets 136.87%277.16M-28.16%94.62M-28.16%94.62M-30.43%97.71M-35.48%103.27M-22.14%117.01M-8.79%131.71M-8.79%131.71M-11.47%140.44M-9.49%160.04M
Liabilities
Current liabilities
Payables -34.73%1.46M-49.35%1.17M-49.35%1.17M-56.33%1.01M-50.19%1.32M-40.15%2.24M-28.14%2.32M-28.14%2.32M2.43%2.32M154.02%2.65M
-accounts payable -34.73%1.46M-49.35%1.17M-49.35%1.17M-56.33%1.01M-50.19%1.32M-40.15%2.24M-28.14%2.32M-28.14%2.32M2.43%2.32M154.02%2.65M
Current accrued expenses -29.12%2.77M-30.53%3.65M-30.53%3.65M-38.27%2.88M-71.39%2.42M-13.32%3.9M-25.54%5.25M-25.54%5.25M-38.19%4.66M8.96%8.46M
Current debt and capital lease obligation 12.08%631K13.25%547K13.25%547K13.46%531K13.47%514K12.15%563K13.65%483K13.65%483K13.59%468K14.11%453K
-Current capital lease obligation 12.08%631K13.25%547K13.25%547K13.46%531K13.47%514K12.15%563K13.65%483K13.65%483K13.59%468K14.11%453K
Current deferred liabilities ------0--0--0--0-41.47%6.76M-35.79%7.57M-35.79%7.57M-9.87%10.91M-28.01%11.03M
Other current liabilities -95.89%245K--640K--640K35.04%763K--768K--5.97M----------565K----
Current liabilities -73.73%5.11M-61.54%6.01M-61.54%6.01M-72.60%5.18M-77.77%5.02M-4.26%19.43M-30.55%15.62M-30.55%15.62M-15.23%18.92M-7.88%22.6M
Non current liabilities
Long term debt and capital lease obligation --0-75.31%199K-75.31%199K-60.02%391K-49.74%575K-46.99%626K-39.99%806K-39.99%806K-34.67%978K-30.50%1.14M
-Long term capital lease obligation --0-75.31%199K-75.31%199K-60.02%391K-49.74%575K-46.99%626K-39.99%806K-39.99%806K-34.67%978K-30.50%1.14M
Non current deferred liabilities ------0--0--0--0--2.86M--2.86M--2.86M--------
Other non current liabilities -20.43%11.88M-21.37%11.84M-21.37%11.84M7.96%14.74M6.09%14.69M5.34%14.93M3.44%15.05M3.44%15.05M-11.84%13.65M-13.19%13.85M
Total non current liabilities -35.50%11.88M-35.72%12.04M-35.72%12.04M3.41%15.13M1.83%15.27M19.96%18.42M17.78%18.72M17.78%18.72M-13.85%14.63M-14.81%14.99M
Total liabilities -55.12%16.99M-47.46%18.04M-47.46%18.04M-39.46%20.31M-46.02%20.29M6.17%37.85M-10.53%34.34M-10.53%34.34M-14.64%33.55M-10.78%37.59M
Shareholders'equity
Share capital 1.99%1.44B0.81%1.42B0.81%1.42B0.78%1.42B0.98%1.42B2.83%1.42B4.46%1.41B4.46%1.41B4.57%1.41B4.40%1.4B
-common stock 1.99%1.44B0.81%1.42B0.81%1.42B0.78%1.42B0.98%1.42B2.83%1.42B4.46%1.41B4.46%1.41B4.57%1.41B4.40%1.4B
Retained earnings 11.72%-1.21B-2.49%-1.38B-2.49%-1.38B-3.17%-1.38B-4.13%-1.37B-5.91%-1.37B-5.48%-1.35B-5.48%-1.35B-6.10%-1.33B-6.23%-1.31B
Paid-in capital -9.54%74.26M1.55%83.32M1.55%83.32M2.28%83.29M1.07%82.63M2.33%82.09M0.96%82.05M0.96%82.05M2.36%81.43M5.89%81.75M
Gains losses not affecting retained earnings -0.06%-48.2M0.08%-48.1M0.08%-48.1M-0.08%-48.13M0.25%-48.19M0.42%-48.17M0.59%-48.14M0.59%-48.14M1.62%-48.09M2.34%-48.31M
Total stockholders'equity 228.68%260.18M-21.35%76.58M-21.35%76.58M-27.59%77.4M-32.24%82.98M-30.95%79.16M-8.16%97.37M-8.16%97.37M-10.43%106.89M-9.09%122.45M
Total equity 228.68%260.18M-21.35%76.58M-21.35%76.58M-27.59%77.4M-32.24%82.98M-30.95%79.16M-8.16%97.37M-8.16%97.37M-10.43%106.89M-9.09%122.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More